Ausgabe 1/2010
Special Issue: The proof of efficacy in psychopharmacology - Clinical studies, metanalyses and evidence-based medicine
Inhalt (9 Artikel)
Special Issue - Editorial
The proof of efficacy in psychopharmacology: clinical studies, metaanalysis and evidence-based medicine
Siegfried Kasper
Special Issue
Principle standards and problems regarding proof of efficacy in clinical psychopharmacology
Hans-Jürgen Möller, Karl Broich
Special Issue
Meta-analyses: a method to maximise the evidence from clinical studies?
Wolfgang Maier, Hans-Jürgen Möller
Special Issue
Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations
Hans-Jürgen Möller, Wolfgang Maier
Original Paper
Metabolic syndrome: a follow-up study of acute depressive inpatients
N. Richter, G. Juckel, H.-J. Assion
Original Paper
Improving outpatient treatment in schizophrenia: effects of computerized guideline implementation—results of a multicenter-study within the German Research Network on Schizophrenia
B. Janssen, S. Ludwig, H. Eustermann, R. Menke, M. Haerter, M. Berger, G. Adam, U. Seemann, W. Kissling, W. Gaebel
Original Paper
The European Post-marketing Observational Sertindole Study: an investigation of the safety of antipsychotic drug treatment
Siegfried Kasper, Hans-Jürgen Möller, Anthony Hale
Original Paper
18FDG PET study of amygdalar activity during facial emotion recognition in schizophrenia
Emilio Fernandez-Egea, Eduard Parellada, Francisco Lomeña, Carles Falcon, Javier Pavia, Anna Mane, Guillermo Horga, Miguel Bernardo
Original Paper
Neuregulin-1 genotypes and eye movements in schizophrenia
H. Magnus Haraldsson, Ulrich Ettinger, Brynja B. Magnusdottir, Andres Ingason, Samuel B. Hutton, Thordur Sigmundsson, Engilbert Sigurdsson, Hannes Petursson